Indeed, FAK gene has been found to be amplified in over 40% of breast cancer specimens while being minimal in benign breast epithelium, thus linking its overexpression to tumorigenesis, progression, metastatic disease, an increased risk of recurrence, and reduced mammary cancer survival [37–40]. This evidence concerns the gene PTK2 and breast carcinoma.